Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model
2022Canadian Journal of Physiology and PharmacologyJournal
10.1139/cjpp-2022-0176Full text5 citations